TMD — Titan Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$5.70m
- -CA$0.47m
- $17.63m
- 41
- 99
- 11
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -41.9 | -24.2 | -14.9 | -42.5 | 6.95 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -17.4 | 28 | -12.1 | 1.97 | 1.23 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 13.3 | -4.92 | -10.4 | 12.2 | -3.68 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -46 | -0.845 | -36.6 | -27.6 | 4.68 |
Capital Expenditures | -0.458 | -0.599 | -0.755 | -1.02 | -0.213 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | — | 0.237 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.458 | -0.599 | -0.755 | -1.02 | 0.024 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 35.8 | 26.1 | 44.2 | -0.419 | -0.451 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.7 | 24.7 | 6.84 | -29 | 4.25 |